Dr. Mark B. Sender, MD

Dr. Sender practices at Genesis Healthcare Partners in San Diego, California.

Dr. Sender's NPI, 1013097534, was assigned on October 17, 2006. Dr. Sender graduated from Emory School of Medicine in 1981. Dr. Sender's California license number on file is G48510.

Dr. Sender's primary practice is Genesis Healthcare Partners, at 3366 5th Ave, San Diego, CA 92103 in San Diego County. The practice phone is (760) 436-4558.

Dr. Sender's primary practice is Genesis Healthcare Partners in San Diego, California. Dr. Sender is also affiliated with Henry Mayo Newhall Hospital. The medical group on file is Unio Specialty Care, Urology, Encinitas (formerly Genesis Healthcare Partners). Dmand AI also links Dr. Sender to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sender practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Sender's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Sender is board certified in urology by the American Board of Urology. Dr. Sender has a license on file in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Sender treats.

CMS data shows 40,690 Medicare services from Dr. Sender across 37 procedure codes in 2024, for 655 Medicare patients. Medicare paid $313,504 for them.

CMS counts 655 Medicare patients who saw Dr. Sender in 2024. The largest group is 65 to 74, with 284 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sender's median patient age at 67, with 23% women.

In 2024, Dr. Sender wrote 2,478 Medicare Part D claims for 490 patients. 85% of them were for generic drugs. CMS names the drug for 2,294 of them, across 28 drugs with 11 or more claims each, at $381,609 in total drug cost. In 2023, CMS named 2,302 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Sender for performance year 2024, reported as part of a group. Dr. Sender accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sender as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 520 general payments to Dr. Sender from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. SN Holdings, LLC paid the most, $3,125.

Dmand AI lists 2 awards for Dr. Sender.

Dr. Sender graduated from Emory School of Medicine in 1981. Dr. Sender is a member of ACS and SLS.

Dr. Sender is in network with 15 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.